Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CBL0137

Product Specifications

UNSPSC Description

CBL0137, a curaxin compound, is a histone chaperone facilitates chromatin transcription (FACT) inhibitor. CBL0137 downregulates NF- B and activates p53. CBL0137 restores both histone H3 acetylation and trimethylation. CBL0137 is an anticancer agent. CBL0137 induces cancer cell apoptosis[1].

Target Antigen

Histone Acetyltransferase; MDM-2/p53; NF-κB

Type

Reference compound

Related Pathways

Apoptosis;Epigenetics;NF-κB

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/CBL-0137.html

Purity

99.68

Solubility

DMSO : 11.11 mg/mL (ultrasonic;warming;heat to 60°C)

Smiles

CC(NCCN1C2=C(C3=C1C=CC(C(C)=O)=C3)C=C(C(C)=O)C=C2)C

Molecular Weight

336.43

References & Citations

[1]Barone TA, et al. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Neuro Oncol. 2017 Feb 1;19(2):186-196. h|[2]Burkhart C, et al. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget. 2014 Nov 30;5(22):11038-53.|[3]Ehteda A, et al. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Rep. 2021 Apr 13;35(2):108994.Cell Death Dis. 2024 Oct 27;15(10):779.|Eur J Med Chem. 2024 Apr 15:270:116377.|Adv Mater. 2024 Jul;36(29):e2313991.|Cancer Res. 2021 Jun 1;81(11):3105-3120.|Cell Death Dis. 2020 Dec 2;11(12):1029.|Cell. 2024 Dec 26;187(26):7533-7550.e23.|Mol Med Rep. 2024 Nov;30(5):209.|Oncogene. 2022 Nov 10.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-18935/CBL0137-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-18935/CBL0137-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

1197996-80-7

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Il31ra (NM_139299) Mouse Tagged ORF Clone Lentiviral Particle
MR216199L4V 200 µL

Il31ra (NM_139299) Mouse Tagged ORF Clone Lentiviral Particle

Ask
View Details
WDR89, CT (WDR89, C14orf150, WD repeat-containing protein 89) (MaxLight 650)
MBS6363475-01 0.1 mL

WDR89, CT (WDR89, C14orf150, WD repeat-containing protein 89) (MaxLight 650)

Ask
View Details
WDR89, CT (WDR89, C14orf150, WD repeat-containing protein 89) (MaxLight 650)
MBS6363475-02 5x 0.1 mL

WDR89, CT (WDR89, C14orf150, WD repeat-containing protein 89) (MaxLight 650)

Ask
View Details
Pbx3 (NM_016768) Mouse Tagged Lenti ORF Clone
MR206922L4 10 µg

Pbx3 (NM_016768) Mouse Tagged Lenti ORF Clone

Ask
View Details
CHN 1 (CHN1) (NM_001822) Human Mass Spec Standard
PH322163 10 µg

CHN 1 (CHN1) (NM_001822) Human Mass Spec Standard

Ask
View Details
REPIN1 Double Nickase Plasmid (m2)
sc-425537-NIC-2 20 µg

REPIN1 Double Nickase Plasmid (m2)

Ask
View Details